University of Utah researchers led an international team of scientists that is the first to report on the previously undescribed ability of platele...
As scientists work to find new treatments for Pompe disease -- the devastating genetic "villain" that drives the efforts of the main characters in ...
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), announced the execution of an agreement...
